Erin McDermott moderates the webinar examining the rise of counterfeit life sciences products, including illicit online pharmacies, unauthorized imports,, falsified medicines, and compounded GLP-1s. Panelists will discuss how these products reach patients, recent enforcement and litigation trends, the impact on manufacturers, and compensable harms.
For more information on this event, click here.

